Previous 10 | Next 10 |
2024-06-14 17:53:40 ET Summary Vanguard Health Care ETF focuses on investing in successful healthcare companies with $20 billion in assets and a low expense ratio of 0.10%. Top holdings include Eli Lilly, UnitedHealth Group, and Johnson & Johnson, offering potential for growth...
2024-06-14 15:55:36 ET More on Bristol-Myers Squibb Company , Gilead Sciences, etc. Bristol-Myers Squibb: Move Investing Time Horizon To 2025, At Least Gilead Sciences, Inc. (GILD) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Bristol-Myers...
2024-06-14 11:23:25 ET More on Johnson & Johnson Johnson & Johnson: Market Will Regret The Overreaction Cancer victims seek court order to block J&J’s bankruptcy bid J&J in $700M settlement with states over marketing of talc products Jo...
TALVEY® (talquetamab-tgvs) demonstrates highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma PR Newswire 24-month overall survival rate of 67 percent achieved with TALVEY ® 0.8 mg/kg biweekly dosing in the Phase 1/2 Monum...
2024-06-13 18:32:48 ET Summary Boston Scientific Corporation is outperforming its peers in the med-tech sector with exceptional growth driven by key products like Farapulse and Watchman. Farapulse and Watchman are well-appreciated drivers with significant upside, but other contrib...
2024-06-13 15:02:59 ET More on Xencor Seeking Alpha’s Quant Rating on Xencor Historical earnings data for Xencor Financial information for Xencor Read the full article on Seeking Alpha For further details see: Xencor to regain rights from J...
2024-06-13 14:03:52 ET Summary Contineum Therapeutics, Inc. PIPE-791 is being developed for the treatment of neuroinflammatory disorders like idiopathic pulmonary fibrosis and Progressive Multiple Sclerosis. The global idiopathic pulmonary fibrosis market size is projected to reac...
2024-06-12 17:45:04 ET Summary Kenvue (KVUE) was created as the result of a spinoff from Johnson & Johnson and encompasses the consumer side of the business. KVUE manages a wide array of products within each segment, but sales volume remains vulnerable to consumer spending. ...
2024-06-12 16:38:08 ET Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference Call June 12, 2024, 02:00 PM ET Company Participants Jennifer Taubert - Executive Vice President, Innovative Medicine John Reed - Executive Vice President, Innov...
2024-06-12 15:34:26 ET More on Johnson & Johnson Johnson & Johnson: Market Will Regret The Overreaction Johnson & Johnson (JNJ) Bernstein's 40th Annual Strategic Decisions Conference - (Transcript) Johnson & Johnson: Vital Signs Decent, A Compelling V...
News, Short Squeeze, Breakout and More Instantly...
Assa Abloy AB ADR (ASAZY) is expected to report for Q2 2024 First Horizon Corporation (FHN) is expected to report $0.37 for Q2 2024 Community Trust Bancorp Inc. (CTBI) is expected to report $1.03 for Q2 2024 Cohen & Steers Inc (CNS) is expected to report for Q2 2024 First Indu...
Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2024 of $1.24 per share on the company’s common stock. The dividend is payable on September 10, 2024 to shareholders of record at the close of business on Aug...
SANTA ANA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer (&...